Form 4: Vita Coco CFO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Vita Coco Company's Chief Financial Officer, Corey Baker, sold 4,000 shares of common stock in two transactions in mid-March 2026, pursuant to a pre-arranged Rule 10b5-1 trading plan.
Summary
- Corey Baker, Chief Financial Officer of Vita Coco Company, Inc. (COCO), sold a total of 4,000 shares of common stock.
- The sales occurred on March 13, 2026, and March 16, 2026.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan.
- On March 13, 2026, 2,000 shares were sold at $58.86 per share.
- On March 16, 2026, another 2,000 shares were sold at $57.98 per share.
- Following these sales, Corey Baker directly beneficially owns 31,951 shares of common stock.
- Baker also holds several non-qualified stock options with various exercise prices and vesting schedules, totaling 56,197 underlying shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. While insider selling can sometimes be a negative signal, the execution under a Rule 10b5-1 plan suggests a pre-determined financial management strategy rather than a reaction to adverse company news.
Positives
- The sales were conducted under a Rule 10b5-1 trading plan, indicating they were pre-scheduled and not necessarily a reaction to new, negative company information.
Negatives
- A Chief Financial Officer selling shares could be perceived negatively by some investors, even if pre-planned, as it reduces their direct equity stake in the company.
Risks
- No specific risks are mentioned in the filing itself, beyond the inherent perception of insider selling.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Management Comments
- The filing does not contain any direct quotes or paraphrased statements from company management.
Industry Context
StockSavvy.ai notes that insider sales, even when pre-planned via a 10b5-1 plan, are routinely monitored by investors for potential signals about management's confidence. In the consumer beverage industry, such transactions are typically viewed in the context of broader market conditions and the company's recent performance, rather than as standalone indicators of distress, especially when part of a scheduled plan.
Comparison to Industry Standards
- NA
Stakeholder Impact
- Shareholders may note the reduction in the CFO's direct equity stake, though the 10b5-1 plan mitigates concerns about immediate negative implications.
Next Steps
- The filing does not mention any specific future actions, events, or milestones beyond the vesting schedules of the stock options.
Key Dates
| Date | Description |
|---|---|
| 03/10/2024 | First annual installment vesting date for a non-qualified stock option with an exercise price of $16.91. |
| 03/04/2025 | First annual installment vesting date for a non-qualified stock option with an exercise price of $26.18. |
| 03/10/2025 | Vesting date for 30% of non-qualified stock options with exercise prices of $24.35 and $27.59. |
| 03/10/2026 | Vesting date for 20% of non-qualified stock options with exercise prices of $24.35 and $27.59. |
| 03/13/2026 | Transaction date for the sale of 2,000 shares of common stock. |
| 03/16/2026 | Transaction date for the sale of 2,000 shares of common stock. |
| 03/17/2026 | Signature date of the Form 4 filing. |
| 03/10/2027 | Vesting date for 10% of non-qualified stock options with exercise prices of $24.35 and $27.59. |
| 03/10/2033 | Expiration date for a non-qualified stock option with an exercise price of $16.91. |
| 05/10/2033 | Expiration date for a non-qualified stock option with an exercise price of $24.35. |
| 08/07/2033 | Expiration date for a non-qualified stock option with an exercise price of $27.59. |
| 03/04/2034 | Expiration date for a non-qualified stock option with an exercise price of $26.18. |
| 03/04/2035 | Expiration date for a non-qualified stock option with an exercise price of $33.36. |
Recommendation
holdThe insider sale by the CFO, while a reduction in direct ownership, was executed under a pre-arranged 10b5-1 trading plan. This typically indicates personal financial planning rather than a lack of confidence in the company's future. Without additional financial or operational news, this transaction alone does not warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.
Keywords
Vita Coco Company, COCO, Corey Baker, CFO, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Beneficial Ownership, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.